DexCom, Inc. (1DXCM)
MTA
Closed
Aug 25, 2026
Day's Range
77.6052 wk Range
47.31Overview - 1DXCM - DexCom, Inc.
Key Statistics
Valuation
Enterprise Value
25.12B
P/E (Trailing)
‪36.22‬
PEG Ratio
‪0.87‬
Price / Sales (TTM)
‪5.96‬
Price / Book
‪13.21‬
EV / EBITDA
‪20.90‬
Profitability
Gross Margin
‪63.43%‬
Profit Margin
‪20.11%‬
Operating Margin
‪24.32%‬
Return on Assets
‪10.33%‬
Return on Equity
‪38.49%‬
Ownership
Shares Outstanding
377.40M
Float
375.95M
Held by Insiders
‪0.27%‬
Held by Institutions
‪106.34%‬
Price stats
Beta
‪1.41‬
50-Day Avg
‪67.18‬
200-Day Avg
‪60.04‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1DXCM - DexCom, Inc.
Peers - 1DXCM - DexCom, Inc.
Peer Comparison
Compared with companies in Medical Devices listed on MTA.
- 1DXCMMTADexCom, Inc.23.04BMarket Cap+15.94%52-week change36.02P/E (Trailing)‪20.11%‬Profit Margin
- 1ABTMTAAbbott Laboratories192.46BMarket Cap-14.65%52-week change37.38P/E (Trailing)‪11.64%‬Profit Margin
- 1BSXMTABoston Scientific Corporation128.14BMarket Cap-114.86%52-week change20.79P/E (Trailing)‪17.49%‬Profit Margin
- 1SYKMTAStryker Corporation121.11BMarket Cap-18.60%52-week change34.52P/E (Trailing)‪14.43%‬Profit Margin
- 1MDTMTAMedtronic plc109.86BMarket Cap-0.08%52-week change25.05P/E (Trailing)‪13.20%‬Profit Margin
- 1SHLMTASiemens Healthineers AG51.85BMarket Cap-16.36%52-week change20.54P/E (Trailing)‪9.55%‬Profit Margin
- 1EWMTAEdwards Lifesciences Corporation43.33BMarket Cap+12.14%52-week change53.60P/E (Trailing)‪15.43%‬Profit Margin
Profile Summary - 1DXCM - DexCom, Inc.
About
DexCom, Inc. is a leading medical technology company specializing in continuous glucose monitoring (CGM) systems for diabetes management. Its primary products deliver real-time glucose readings through small, wearable sensors that provide accurate, personalized data to users, simplifying daily monitoring and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
